Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Evaluation of a type 1 diabetes serum cohort by SELDI-TOF MS protein profiling

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. A Parallel Reaction Monitoring Mass Spectrometric Method for Analysis of Potential CSF Biomarkers for Alzheimer's Disease

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Candidate biomarker verification: Critical examination of a serum protein pattern for human colorectal cancer

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Proteomic biomarkers for overall and progression-free survival in ovarian cancer patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Comparison of proteomic biomarker panels in urine and serum for ovarian cancer diagnosis

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. The urinary proteome in diabetes and diabetes-associated complications: New ways to assess disease progression and evaluate therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Evaluation of Serum Insulin-like Factor 3 Quantification by LC-MS/MS as a Biomarker of Leydig Cell Function

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS/MS

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Terror på hjernen

    Research output: Book/ReportBookCommunication

  4. Functional brown adipose tissue and sympathetic activity after cold exposure in humans with type 1 narcolepsy

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. [Sar1, Ile4, Ile8]-angiotensin II Potentiates Insulin Receptor Signalling and Glycogen Synthesis in Hepatocytes

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

Proteomics analysis of serum from patients with type 1 diabetes (T1D) may lead to novel biomarkers for prediction of disease and for patient monitoring. However, the serum proteome is highly sensitive to sample processing and before proteomics biomarker research serum cohorts should preferably be examined for potential bias between sample groups. SELDI-TOF MS protein profiling was used for preliminary evaluation of a biological-bank with 766 serum samples from 270 patients with T1D, collected at 18 different paediatric centers representing 15 countries in Europe and Japan over 2 years (2000-2002). Samples collected 1 (n = 270), 6 (n = 248), and 12 (n = 248) months after T1D diagnosis were grouped across centers and compared. The serum protein profiles varied with collection site and day of analysis; however, markers of sample processing were not systematically different between samples collected at different times after diagnosis. Three members of the apolipoprotein family increased with time in patient serum collected 1, 6, and 12 months after diagnosis (ANOVA, p<0.001). These results support the use of this serum cohort for further proteomic studies and illustrate the potential of high-throughput MALDI/SELDI-TOF MS protein profiling for evaluation of serum cohorts before proteomics biomarker research.

Original languageEnglish
JournalProteomics - Clinical Applications
Volume3
Issue number3
Pages (from-to)383-393
Number of pages11
ISSN1862-8346
DOIs
Publication statusPublished - Mar 2009

    Research areas

  • Journal Article

ID: 30972036